Stay updated on KN035: Pembrolizumab in Advanced Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the KN035: Pembrolizumab in Advanced Solid Tumors Clinical Trial page.

Latest updates to the KN035: Pembrolizumab in Advanced Solid Tumors Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedAdded revision entry v3.4.2 and removed v3.4.1 from the Record History page, updating the displayed site version history.SummaryDifference0.1%

- Check15 days agoChange DetectedAdded a new revision entry (v3.4.1) to the record history and removed a funding-status notice along with an older revision (v3.4.0). These are administrative updates to the page's history and do not affect the underlying study data or public-facing trial information.SummaryDifference0.8%

- Check22 days agoChange DetectedA site-wide notice about government funding and operating status was added at the top of the page, but the study record content remains unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.7%

- Check29 days agoChange DetectedThe page now includes a glossary display option and color-coded highlights for additions and deletions, with a new revision label (v3.4.0). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference1%

- Check36 days agoChange DetectedThe record history now lists a new revision entry v3.3.4 and removes v3.3.3 from the history. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check65 days agoChange DetectedAdded a new revision version (Revision: v3.3.3) to the study record history; removed the HHS Vulnerability Disclosure link and Revision: v3.3.2 from the footer. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

Stay in the know with updates to KN035: Pembrolizumab in Advanced Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the KN035: Pembrolizumab in Advanced Solid Tumors Clinical Trial page.